Pyxis Oncology Inc (PYXS) Financials

$3.89

$0.00 (0.00%)

As on 08-Sep-2026 16:28EDT

Market cap

$324 Mln

Revenue (TTM)

$11 Mln

P/E Ratio

--

P/B Ratio

27.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	11.04	13.86	16.15	--	--	--
Cost of Revenue	0.03	2.39	0.48	2.00	1.84	1.25
Gross Profit	11.01	11.47	15.67	-2.00	-1.84	-1.25
Operating Expenses	103.12	95.89	105.13	82.20	123.48	69.72
Operating Profit (EBIT)	-92.11	-84.42	-89.46	-82.20	-123.48	-69.72
Other Income	--	--	--	--	2.76	-6.26
Profit before Tax	-87.62	-78.24	-79.50	-73.79	-120.72	-75.98
Provision for Tax	1.10	1.39	-2.16	1.78	-2.76	5.56
Profit after Tax (Net Income)	-88.73	-79.62	-77.33	-73.79	-117.95	-75.98
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-120.72	-75.98

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	11.44	53.41	120.75	125.70	160.82	261.31
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	16.01	16.98	18.75	22.26	18.92	12.12
Current Liabilities	27.47	21.13	17.68	25.76	31.63	18.71
Total Liabilities	82.40	91.52	157.18	173.73	211.38	280.02

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	18.19	19.42	24.74	49.12	24.77	1.35
Current Assets	36.73	72.11	132.44	124.60	186.61	278.67
Total Assets	82.40	91.52	157.18	173.73	211.38	280.02
Total Debt*	17.83	18.67	20.20	21.33	18.92	0.17
Net Current Assets	9.26	50.97	114.76	98.85	154.98	259.97

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-63.50	-57.67	-70.71	-89.34	-35.33
Cash Flow from Investing Activities	--	58.86	8.16	-104.85	-6.40	-0.59
Cash from Financing Activities	--	0.59	59.33	5.93	0.18	304.04
Net Cash Inflow / Outflow	--	--	--	--	-95.55	268.13

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.41	-1.28	-1.27	-1.65	-3.37	-2.39
Cash EPS ($)	--	-1.21	-1.22	-1.62	-3.35	-2.37
Adjusted Book Value ($)	--	0.86	1.99	2.81	4.60	8.23
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.02	-0.95	-1.58	-2.56	-1.11
Free Cash Flow per Share ($)	--	-1.02	-0.95	-1.73	-2.74	-1.13

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-74.75	-53.70	-45.16	-53.47	-61.61
ROE (%)	-273.65	-91.43	-62.75	-51.51	-55.88	-61.85
ROA (%)	-79.47	-64.03	-46.74	-38.32	-48.01	-52.37
EBIT Margin (%)	-793.84	-564.55	-424.23	--	--	--
Net Margin (%)	-803.83	-574.55	-478.95	--	-4,267.47	1,214.05
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	77.40	-0.14	--	--	--	--
EBIT Growth (%)	-10.17	-14.22	7.17	40.24	-62.53	-492.26
Net Profit Growth (%)	7.85	-2.96	-4.80	37.44	-55.25	-492.26
EPS Growth (%)	10.92	-0.01	0.23	0.51	-0.41	-3.13
Book Value Growth (%)	-87.37	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.90	-1.22	-1.09	-0.40	-4.58
Price / Book Value	27.38	1.34	0.78	0.64	0.29	1.33
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	1.09	-0.32	0.18	0.24	0.92	-0.98
Close Price ($)	3.01	1.15	1.56	1.80	1.34	10.97
High Price ($)	5.55	5.55	6.85	6.92	11.50	19.00
Low Price ($)	0.97	0.83	1.49	1.27	1.10	7.90
Market Cap ($ Cr)	324.46	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.35	0.17	0.17	0.12	0.00
Short term debt to equity ratio	0.16	0.03	0.01	0.01	--	0.00
Current Ratio	1.34	3.41	7.49	4.84	5.90	14.90
Quick Ratio	1.34	--	--	--	5.87	--
Interest Coverage	--	--	--	--	-44.67	-12.14

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	5.05	--	--	--	--
Asset Turnover	0.10	0.11	0.10	--	--	--
Receivable days	--	18.45	0.48	--	--	--
Inventory Days	--	--	--	159.61	173.87	--
Payable days	--	1,204.04	3,366.07	1,003.80	1,894.68	1,901.87
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.